SCHEMBL363513

SCHEMBL363513

CC(O)(C(N)=O)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.56
MEN1 O00255 4/20 0.56
POLB P06746 1/20 0.47
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
HIF1A Q16665 1/20 0.45
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MIF P14174 1/20 0.42
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11303263 0.81 KMT2A (0.58) KMT2AMEN1POLBTSHRMAPK1
SCHEMBL568903 0.81 KMT2A (0.58) KMT2AMEN1POLBTSHRMAPK1
SCHEMBL2799510 0.81 KMT2A (0.63) KMT2AMEN1POLBTSHRMAPK1
SCHEMBL10887061 0.79 KMT2A (0.50) KMT2AMEN1POLBTSHRMAPK1
SCHEMBL10816148 0.78 TSHR (0.48) KMT2AMEN1POLBTSHRMAPK1
Atrolactamide SCHEMBL78236 0.78 MAPT (0.65) KMT2APOLBTSHRHIF1AMAPT
SCHEMBL11699545 0.78 SRD5A2 (0.55) KMT2AMEN1TSHRSMN1; SMN2MAPT
SCHEMBL6203218 0.78 POLB (0.55) KMT2AMEN1POLBTSHRMAPK1
SCHEMBL29570723 0.77 MEN1 (0.48) KMT2AMEN1POLBTSHRMAPK1
SCHEMBL11836094 0.76 KMT2A (0.52) KMT2AMEN1POLBTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593424-A1 NOVEL ARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES Medeia Therapeutics Ltd (FI) 2013-05-22 EP claimed
WO-2012007644-A1 NOVEL ARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES MEDEIA THERAPEUTICS LTD (FI) 2012-01-19 WO claimed